Medical Access Program for Datopotamab Deruxtecan in EGFRm NSCLC Patients
Clinical trial NCT06279728 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT06279728
- Sponsor
- Daiichi Sankyo
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.